{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:22:07Z","timestamp":1759940527564},"reference-count":61,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T00:00:00Z","timestamp":1110931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Leiomyoma and hyperprolactinaemia are both progesterone\u2010dependent diseases. Hormone\u2010related genes, such as the progesterone receptor (PGR), might be involved in their pathogenesis.<\/jats:p><jats:p><jats:bold>Design and measurements\u2002<\/jats:bold> Subjects were divided into three groups: (i) leiomyoma (<jats:italic>n<\/jats:italic>\u00a0=\u00a0120); (ii) hyperprolactinaemia (<jats:italic>n<\/jats:italic>\u00a0= 101); (iii) normal controls (<jats:italic>n<\/jats:italic>\u00a0=\u00a0140). We investigated the Alu (306\u2010bp DNA) insertion in intron G of the PGR gene in all individuals. PGR gene polymorphisms [T1 (wild\u2010type); T2 (PROGINS, with Alu insertion)] were determined by PCR and electrophoresis. Genotype and allele frequencies of the PROGINS in each group were detected and compared.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> We observed no significant difference of the PGR*T1\/T2 genotypes and allele frequencies between leiomyoma and other two groups. The proportions of T1 homozygote\/heterozygote\/T2 homozygote in each group were (i) 90\/8\u00b73\/1\u00b77%; (ii) 84\u00b72\/9\u00b79\/5\u00b79%; (iii) 92\u00b79\/6\u00b74\/0\u00b77%. In contrast, a higher percentage of T2\u2010related genotype and allele were noted in hyperprolactinaemic women compared to other two groups. The proportions of T1\/T2 alleles in each group were: (i) 94\u00b72\/5\u00b78%; (ii) 89\u00b71\/10\u00b79%; (iii) 96\u00b71\/3\u00b79%.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The PROGIN*T2\u2010related genotype and allele are related to a higher susceptibility to hyperprolactinaemia. The PROGINS polymorphism is not associated with leiomyoma development.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2005.02251.x","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T11:31:27Z","timestamp":1111663887000},"page":"492-497","source":"Crossref","is-referenced-by-count":8,"title":["PROGINS Alu sequence insertion is associated with hyperprolactinaemia but not leiomyoma susceptibility"],"prefix":"10.1111","volume":"62","author":[{"given":"Yao\u2010Yuan","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian\u2010Pan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin\u2010I.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi\u2010Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching\u2010Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chich\u2010Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,3,16]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1018889"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870110102"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/317258a0"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115042"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmh019"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.5787"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(82)90676-7"},{"key":"e_1_2_5_9_2","first-page":"BR25","article-title":"Analysis of estrogen receptor (ER\u03b1 and ER\u03b2) and progesterone receptor (PR) polymorphisms in uterine leiomyomas","volume":"9","author":"Massart F.","year":"2003","journal-title":"Medical Science Monitor"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)03378-2"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/9.suppl_1.63"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200204000-00002"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00334-2"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)01091-6"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000127082"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312013092240"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90607-0"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00284486"},{"key":"e_1_2_5_19_2","first-page":"2743","article-title":"Ovarian carcinoma\u2010associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion","volume":"55","author":"Rowe S.M.","year":"1995","journal-title":"Cancer Research"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/7.1.8"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2002.00924.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02083.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120301717164903"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000030108"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.1.51"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)04563-6"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.2307\/3454308"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/713602595"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(02)00230-7"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/713602771"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000127086"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000127192"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-195-43136"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.141.10.3842"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.10.7070"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.1179"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod63.4.1192"},{"key":"e_1_2_5_38_2","first-page":"665","article-title":"Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility","volume":"94","author":"Andersen T.I.","year":"1994","journal-title":"Human Genetics"},{"key":"e_1_2_5_39_2","first-page":"3534","article-title":"Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci","volume":"56","author":"Jiang X.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014813931765"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-5576(97)86082-0"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)02984-3"},{"key":"e_1_2_5_43_2","first-page":"2348","article-title":"Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50","volume":"60","author":"Wang\u2010Gohrke S.","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002139900364"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02076.x"},{"key":"e_1_2_5_46_2","first-page":"5236","article-title":"A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk","volume":"63","author":"De Vivo I.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0002-9378(03)00517-9"},{"key":"e_1_2_5_48_2","first-page":"4142","article-title":"Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes","volume":"59","author":"Shintani S.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02073.x"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh245"},{"key":"e_1_2_5_51_2","first-page":"5145","article-title":"PROGINS polymorphism of progesterone receptor is increased in female offspring with maternal exposure to diethylstilbestrol","volume":"20","author":"Engehausen D.G.","year":"2000","journal-title":"Anticancer Research"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802481"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh046"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20011120)95:6<394::AID-IJC1070>3.0.CO;2-X"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2004.01.005"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(02)00015-5"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-5576(01)00123-X"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192172299"},{"key":"e_1_2_5_59_2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1055-9965.1084.13.6","article-title":"No association between the progesterone receptor gene +331G\/A polymorphism and breast cancer","volume":"13","author":"Feigelson H.S.","year":"2004","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2003.04.002"},{"key":"e_1_2_5_61_2","first-page":"439","article-title":"The progesterone receptor exon 4 Val660Leu G\/T polymorphism and risk of breast cancer in Australian women","volume":"11","author":"Spurdle A.B.","year":"2002","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.5.717"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2005.02251.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2005.02251.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:32:56Z","timestamp":1697232776000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2005.02251.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,16]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.1365-2265.2005.02251.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02251.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,16]]}}}